San Francisco, CA, United States of America

Dimitar Filipov


 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Dimitar Filipov: Innovator in Pharmaceutical Processes

Introduction

Dimitar Filipov is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for preparing various compounds. With a total of 3 patents to his name, Filipov's work has the potential to impact the industry significantly.

Latest Patents

Filipov's latest patents include groundbreaking processes for preparing a pan-JAK inhibitor and related intermediate compounds. This patent provides detailed methodologies for creating a crystalline form of a specific compound, which is crucial for further pharmaceutical applications. Another notable patent focuses on the preparation of 2-(1-(tert-butoxycarbonyl)piperidine-4-yl)benzoic acid, which serves as an important intermediate for synthesizing ampreloxetine and its salts.

Career Highlights

Throughout his career, Dimitar Filipov has worked with prominent companies in the pharmaceutical sector. He has been associated with Theravance Biopharma R&D IP, LLC and Theravance Biopharma Antibiotics IP, LLC. His work in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug development.

Collaborations

Filipov has collaborated with esteemed colleagues such as Norbert Kraut and Matteo Conza. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Dimitar Filipov stands out as a dedicated inventor whose work in pharmaceutical processes is paving the way for future advancements. His contributions are not only valuable to his companies but also to the broader scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…